This volume reviews comprehensively the present understanding of the clinical pharmacology and therapeutics of currently available antihypertensive agents. As fewer new molecules are entering development it becomes increasingly important to utilise existing drugs in a way that exploits their full potential through a greater understanding of their molecular biology and pharmacogenomics.
Volume in Handbook of Hypertension series.
International range of expert contributors.
Systematically reviews the clinical pharmacology of all the antihypertensive agents.
Also covers treatment of hypertension in special patient goups.
Includes covearge of latest clinical trials and prospects for the future.
By Gordon McInnes, BSc, MD, FRCP, FFPM, FAHA, Division of Cardiovascular and Medical Sciences, Gardiner Institute, Western Infirmary, Glasgow, UK
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and handheld, we are able to supply the information you need in the most convenient format.